Prime Healthcare and Steer Health Announce Strategic Partnership to Improve Patient Outcomes and Access to Care

Investments in digital tools and innovative communication solutions provide an improved patient experience ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare, an award-winning national health system, and Steer Health, an innovative AI enabled growth and automation platform, announced a strategic enterprise partnership to create a next-generation consumer engagement experience for Prime’s 45 hospitals and more than 300 outpatient locations … [Read more…]

California Cancer Coalition Celebrates State Legislature’s Passage of Landmark Cancer Care Access Bill, Urges Governor Newsom to Sign

Both chambers of California legislature unanimously pass the California Cancer Care Equity Act (SB 987) SACRAMENTO, Calif.–(BUSINESS WIRE)–The Cancer Care Is Different (CCID) Coalition applauds the California State Legislature for passing the California Cancer Care Equity Act (SB 987), a bill that would expand access to specialized cancer care for Medi-Cal patients who receive a … [Read more…]

Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a live webcast at 2:30 p.m. EDT on Monday, September 26, 2022, with Caroline Roan, Chief Sustainability Officer and Senior Vice President, Global Health and Social Impact, and Louise Proud, Vice President, Environment, Health and Safety, who will … [Read more…]

ILiAD Biotechnologies Announces $42.8M Financing Round to Advance BPZE1 Pertussis Vaccine

WESTON, Fla.–(BUSINESS WIRE)–ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most advanced next generation pertussis vaccine, today announced the closing of a $42.8 million Class D round of financing. These funds will enable the company to conduct a Phase 2b Human Challenge study to determine if vaccination with BPZE1 prevents colonization … [Read more…]

Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference. Tricida will provide a company overview, business update and progress on the company’s key initiatives. The presentation will be accessible on the Tricida website at IR.Tricida.com on Monday, September 12, 2022 at … [Read more…]

Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research

CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee CEO Matt Walz has been named to the 2022 PharmaVoice 100 — an annual list that recognizes the most inspiring people in the life-sciences industry – for his work to increase access, diversity, and efficiency in clinical research. “With the number of clinical trials over the next five … [Read more…]

Asia Pacific External Urine Management Products Market to Witness 5.6% Growth Through 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific External Urine Management Products Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Offline and Online), By Product, By End- use (Hospitals, Clinics, Home Care Settings), By Country and Growth Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific External Urine Management Products Market … [Read more…]

Pelvic Fragility Fracture Patient at the University of Missouri in Columbia is the 100th Person Treated with CurvaFix IM Implant for Pelvic Fracture Fixation

BELLEVUE, Wash.–(BUSINESS WIRE)–#CurvaFixImplant—CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the completion of the 100th surgical procedure using the CurvaFix® IM Implant to repair a pelvic fragility fracture for a geriatric patient at University Hospital at the University of Missouri in Columbia, Mo. The surgery was performed by … [Read more…]

Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression

BURLINGAME, Calif.–(BUSINESS WIRE)–#DepressionTreatment—Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory … [Read more…]

Immunomic Therapeutics Announces the Appointment of Frances Harrison as Senior Vice President, Regulatory Affairs

ROCKVILLE, Md.–(BUSINESS WIRE)–#biotech–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein)-mediated nucleic acid-based immunotherapy, today announced the appointment of Frances Harrison as Senior Vice President, Regulatory Affairs. Ms. Harrison brings to the company more than 30 years of experience in global regulatory strategies and submissions, interactions, … [Read more…]